ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation
W orel N K alhs P K eil F et al ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation Transfusion 2003 43 1153 1161
A and B blood group antigen expression on mixed colony cells and erythroid precursors: Relevance for human allogeneic bone marrow transplantation
B lacklock HA K atz F M ichalevicz R H azlehurst GR D avies L P rentice HG H offbrand AV A and B blood group antigen expression on mixed colony cells and erythroid precursors: relevance for human allogeneic bone marrow transplantation Br J Haematol 1984 58 267 276
Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
L ee J-H L ee K-H K im S L ee J-S K im S-H K won S-W K im W-K Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation Bone Marrow Transplant 2000 25 179 184
Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation
G mur JP B urger J S chaffner A N eftel K O elz O F rey D M etaxas M Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation Blood 1990 75 290 295
Changes of isoagglutinin titers after ABO-incompatible allogeneic stem cell transplantation
L ee JH L ee JH C hoi SJ et al Changes of isoagglutinin titers after ABO-incompatible allogeneic stem cell transplantation Br J Haematol 2003 120 702 710
ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning
B adros A T ricot G T oor A M orris C G uo C M unshi N B arlogie B C ottler -F ox M ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning Transfusion 2002 42 205 209
Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: Evidence for a graft-versus-plasma cell effect
M ielcarek M L eisenring W T orok-Storb B S torb R Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect Blood 2000 96 1150 1156
Allogeneic bone marrow transplantation in multiple myeloma
European Group for Bone Marrow Transplantation
G ahrton G T ura S L jungman P et al. Allogeneic bone marrow transplantation in multiple myeloma European Group for Bone Marrow Transplantation N Engl J Med 1991 325 1267 1273
Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation
M in CK K im DW L ee JW M in WS K im CC Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation Acta Haematol 2000 104 185 192
Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: Response to antithymocyte globulin
B ierman PJ W arkentin P H utchins MR K lassen LW Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin Leuk Lymphoma 1993 9 169 171
Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin
R oychowdhury DF L inker CA Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin Bone Marrow Transplant 1995 16 471 472